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Abstract
Background: Neck-shoulder pain conditions, e.g., chronic trapezius myalgia, have been associated with sensory
disturbances such as increased sensitivity to experimentally induced pain. This study investigated pain sensitivity in
terms of bilateral pressure pain thresholds over the trapezius and tibialis anterior muscles and pain responses after
a unilateral hypertonic saline infusion into the right legs tibialis anterior muscle and related those parameters to
intensity and area size of the clinical pain and to psychological factors (sleeping problems, depression, anxiety,
catastrophizing and fear-avoidance).
Methods: Nineteen women with chronic non-traumatic neck-shoulder pain but without simultaneous anatomically
widespread clinical pain (NSP) and 30 age-matched pain-free female control subjects (CON) participated in the
study.
Results: NSP had lower pressure pain thresholds over the trapezius and over the tibialis anterior muscles and
experienced hypertonic saline-evoked pain in the tibialis anterior muscle to be significantly more intense and
locally more widespread than CON. More intense symptoms of anxiety and depression together with a higher
disability level were associated with increased pain responses to experimental pain induction and a larger area size
of the clinical neck-shoulder pain at its worst.
Conclusion: These results indicate that central mechanisms e.g., central sensitization and altered descending
control, are involved in chronic neck-shoulder pain since sensory hypersensitivity was found in areas distant to the
site of clinical pain. Psychological status was found to interact with the perception, intensity, duration and
distribution of induced pain (hypertonic saline) together with the spreading of clinical pain. The duration and
intensity of pain correlated negatively with pressure pain thresholds.
Keywords: Quantitative sensory testing, trapezius myalgia, muscle, pain, hypersensitivity, centralization, pressure
pain thresholds, pain drawing, pain intensity, questionnaire
Background
Neck shoulder pain remains a major problem in work
tasks with high exposure to awkward working positions,
repetitive movements and movements with high preci-
sion demands. The trapezius muscle is considered parti-
cularly affected. The prevalence of chronic neck-
shoulder pain appears to be higher in women than in
men [1,2]. It causes high socioeconomic costs and
significant loss of quality of life for the individual [3].
Because of limited knowledge of the mechanisms
involved in transition from acute to chronic pain,
attempts to develop effective treatments have had lim-
ited success. The clinical manifestations of chronic pain
conditions include both somatic (e.g., sensory distur-
bances, facilitated pain responses in association with
movements, tense muscles with hyperalgesia for
mechanical pressure/manual palpation) and psychologi-
cal symptoms (e.g., sleeping problems, anxiety, and
depressive symptoms).
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any medium, provided the original work is properly cited.Sensory hypersensitivity (central sensitization is some-
times used as a synonym while others use central sensi-
tization as a term for specific mechanisms in the central
nervous system (CNS)) is a common feature of several
chronic neck-shoulder pain conditions, particularly
those with higher levels of pain intensity and disability
[4].. At the clinical examination, this can be manifested
as increased sensitivity to manual palpation (i.e., pres-
sure), but increased sensitivi t yt oo t h e rs e n s o r ym o d a l -
ities, e.g., heat or cold, have also been described [5-7].
Hypersensitivity to mechanical pressure or thermal pain
is sometimes confined to the neck-shoulder area but
may also be present in remote pain-free areas, even
though the clinical routine examination does not reveal
clinical anatomical widespread pain and/or generalized
hyperalgesia for different types of stimuli [5,8-13]. Wide-
spread deep tissue hyperalgesia has been found in
patients with fibromyalgia, tension-type headache, whi-
plash associated disorders (WAD), idiopathic neck pain,
epicondylalgia, low back pain, pelvic pain syndrome, and
osteoarthritis [8,13-21]. It is generally acknowledged
that the presence of widespread sensory hypersensitivity
provides indication of augmented central pain proces-
sing mechanisms [4,21]. Peripheral and central sensitiza-
tion and alterations in descending inhibition
mechanisms of nociception have been suggested as
three of the underlying mechanisms of chronic muscu-
loskeletal pain in general [22]. It the context of muscle
pain it has been suggested that neurobiological sensitiza-
tion operating at somatic, cognitive and behavioral levels
may increase the prevalence of e.g., sleeping problems,
anxiety and depressive symptoms [23-25]. Another
explanation may be that such symptoms are secondary
consequences of living with chronic pain.
Pain induction in an anatomical region distant from
the clinical pain region is a common strategy to investi-
gate signs of central sensitization and/or alterations in
descending inhibition of neural activity and nociception
at the spinal cord level. Assessments of pain sensitivity
in deep tissue of non-painful regions of the body may
be of importance for better understanding of the devel-
opment of widespread hypersensitivity. Pressure pain
thresholds (PPTs) using algometry have been used exten-
sively to map mechanical sensitivity of mainly deep tis-
sues such as muscles. Another modality (i.e., chemical)
of the pain sensitivity of muscle can be investigated
using the intramuscular hypertonic saline model with
the opportunity to assess both aspects of sensitization
and referred pain [18,26,27]. The hypertonic saline
model has been used extensively to characterize the sen-
sory and motor effects involved in muscle pain, as the
quality of the induced pain is comparable to acute clini-
cal muscle pain and shows both localized and referred
pain characteristics [28]. The anatomical spreading of
experimentally induced muscle pain seems to alter in
chronic musculoskeletal pain conditions; for example,
patients with fibromyalgia experience stronger pain and
larger primary and referred pain areas after hypertonic
saline-evoked muscle pain compared with pain-free con-
trols [19]. Such manifestations were present in the lower
limb muscles, where these patients typically do not
experience ongoing pain. Extended referred pain areas
from the tibialis anterior muscle have also been found
in patients with chronic WAD [18,29].
Both algometry and pain induction using the intra-
muscular saline model are psychophysical tests; i.e., an
objective stimuli but a subjectively reported response by
the tested subject. Noxious psychophysical tests require
cooperation from the subject and attention, concentra-
tion, motivation and mood can reasonably affect the
reports of the subjects tested [30]. A bio-psycho-social
model [31,32] is preferred in clinical management of
chronic pain since a blend of factors - neurobiological,
psychological, coping styles, and contextual factors -
contributes to the development and maintenance of
chronic pain [33-38]. Moreover, psychological factors, e.
g., anxiety, depressive symptoms and fear, appear to play
prominent roles in maladaptive responses to pain and in
pain perpetuation [32,36,39,40]. Hence, it is reasonable
to assume that the psychological status can influence
the reports of pain thresholds during psychophysical
tests in chronic pain conditions.
Chronic WAD has been relatively extensively investi-
gated concerning spreading of hyperalgesia as men-
tioned above. Studies of how widespread sensory
hypersensitivity is in non-traumatic neck-shoulder pain
disorders, e.g., chronic neck-shoulder pain, are, however,
sparse and inconclusive [9,10,41] and psychological
aspects have not been extensively investigated in relation
to pain responses to sensory tests in these patients.
The aim of this explorative study was to further inves-
tigate signs of sensory hypersensitivity, in terms of low-
ered PPTs and more intense responses to painful
hypertonic saline infusion, and the possible relationships
to different psychological factors (sleeping problems,
depression, anxiety, catastrophizing, and fear-avoidance
beliefs) in women with chronic neck-shoulder pain, and
various extent of regional pain, compared with healthy
controls.
Methods
Subjects
The details concerning the recruitment of subjects have
been reported elsewhere [42-44]; here is given a
summary.
In order to recruit subjects with trapezius myalgia
(denoted NSP), the medical reports of former female
outward patients who had been referred to the
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köping University Hospital due to: neck myalgia and
with the international classification of diseases (ICD)
number M79.1, or cervicalgia ICD number M 54.2, or
cervico-brachial syndrome ICD number M 53.1 and
with no other diagnosis were identified. Invitation letters
with information about the study were sent to 220 for-
mer patients. Those who volunteered to participate were
contacted by telephone and 24 of them were invited to
be examined by a standardized clinical neck and
shoulder examination and to complete the Nordic Min-
istry Council Questionnaire (NMCQ) [45], which was
used to survey their present pain.
Eligible subjects for the standardized clinical examina-
tion were those women who reported pain in the des-
cending region of the trapezius muscle during the last
seven days and reported neck and shoulder pain more
than 90 days over the last 12 months. Moreover, sub-
jects should not report pain during the last seven days
from more than three body regions according to the
NMCQ.
The standardised clinical examination [46] was per-
formed to ensure that the subjects met the above cri-
teria and that the subjects also fulfilled the criteria for
trapezius myalgia. This examination included questions
about pain intensity and location of pain, tiredness and
s t i f f n e s si nt h en e c k - s h o u l d e rr e g i o no nt h ed a yo f
examination, and in addition physical tests including;
range of motion and tightness of muscles, pressure pain
threshold and sensitivity, muscle strength and palpation
of tender points. The examiner was a physician (BL),
specialized in occupational medicine. The examiner was
not blinded to if the subject was healthy or had pain.
The following exclusion criteria were used: 1) chronic
widespread pain according to the Manchester definition
[47], i. e., pain from more than two sections of two con-
tralateral limbs and the axial skeleton present for at
least three months, 2) signs of tendinitis or joint affec-
tions in the shoulders at the clinical examination, 3)
prior neck trauma (according to the report of the sub-
ject), 4) rheumatoid arthritis or other systemic diseases,
5) neurological diseases, 6) metabolic diseases, 7) fibro-
myalgia syndrome (determined by tender point exami-
nation and pain drawing according to the ACR criteria
of 1990 [48].
The diagnosis trapezius myalgia was set if the findings
neck pain, tightness of the trapezius muscle (i.e., a feel-
ing of stiffness in the descending region of the trapezius
muscle was reported by the subject at examination of
lateral flexion of the head) and palpable tender parts in
the trapezius muscle were all included. The cervical
spine was to have normal or only slightly decreased
range of motion. The examination protocol allowed the
examiner to identify and exclude the subjects with pain
in the trapezius region that was most likely referred
from painful tendons or nerve compressions in the neck
and shoulder area.
Through these procedures and criteria nineteen
women with chronic neck-shoulder pain, fulfilling the
diagnostic criteria of trapezius myalgia (NSP) were
recruited for the study (mean age: 40 years (range: 28-
48 years); mean height: 168 cm (range: 160-176 cm);
mean weight: 73 kg (range: 49-97 kg)). The median
c h r o n i cp a i nd u r a t i o ni nN S Pw a s1 2 0m o n t h s( r a n g e
36-273 months). The majority (n = 17) of the patients
in the NSP group worked 100% or part-time. One
patient was 100% on sick-leave and one received com-
pensation for unemployment. Eighteen of these NSP
subjects were subsequently included in an experimental
study of repetitive work and psychosocial stress (see
[42-44]).
Thirty age matched healthy women with no neck/
shoulder pain, recruited via advertisements in daily
newspapers, comprised the control group (denoted
CON, mean age: 40 years (range: 26-50 years); mean
height: 168 cm (range: 159-176 cm); mean weight: 67 kg
(range: 51-90 kg)). The controls were assessed using a
brief version of the clinical examination. An exclusion
criterion, in addition to the above mentioned, was the
presence of pain in the neck-shoulder region for more
than 2-3 days during the previous 12 months.
All subjects gave their written informed consent and
the study was approved by the Linköping University
Ethics Committee (Dnr M46-07).
Procedure
At the first visit those who volunteered to participate
were clinically examined (see above) and if they were
assessed suitable for the study, the subjects were sched-
uled for a second visit, 1-2 weeks later, which comprised
different measurements of pain sensitivity. At the time
of the clinical examination (i.e., first visit) they were
given a questionnaire to be completed at home and
instructed to bring it back the next visit. All measure-
ments during the second visit were performed by the
same research nurse, using the same sequence of testing,
starting with pressure pain thresholds, followed by
hypertonic saline infusion for all subjects.
Pressure pain thresholds
Pressure pain thresholds (PPT) were measured with an
electronic algometer (Somedic Production, Stockholm,
Sweden) at three points located in the right and left tra-
pezius muscles, respectively; T1 (medial), T2 (middle),
and T3 (lateral) and at one reference point over the
right and left tibialis anterior muscles of the lower leg.
Two measurements were recorded at each site with
approximately a 1-minute pause between the
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order, starting with the medialpoint over the right trape-
zius muscle, continuing with the corresponding points
on the left side, followed by the reference points over
the right and left tibialis anterior muscles. The contact
area of the algometer probe tip was 1 cm
2 and was cov-
ered with 2-mm-thick rubber to minimize irritation of
the skin. The pressure was applied perpendicularly to
the skin at a rate of 40 kPa/s. A scale on the display
helped the investigator to keep the rate of the pressure
increase fixed. The participants were instructed to
depress a handheld switch at their first perception of
pain, i.e., when the sensation of “pressure” changed to
“pain or discomfort”, at which point the application of
pressure ceased. The registered pressure threshold mea-
sured in kilo Pascals (kPa) was then frozen on the dis-
play unit. To avoid bruising due to tissue damage a cut-
off point was set at 600 kPa. The mean values of T1+T2
+T3 were calculated and presented as results.
A test trial, on a single point over the rhomboid mus-
cles bilaterally, was performed to familiarize the partici-
pant with the procedure. All measurements were carried
out by the same research nurse. The technique has been
found to have a satisfactory repeatability [49].
Induced muscle pain
Experimental muscle pain was induced by injection of
0.5 ml sterile hypertonic saline (5.8%) into the tibialis
anterior muscle of the right lower leg with the subjects
placed comfortably in a sitting position for the injection.
The needle was inserted into the deep mid-portion of
the tibialis anterior muscle. The bolus was injected dur-
ing a 20 s period using a computer-controlled syringe
pump (IVAC, model 770). A tube (IVAC G30303,
extension set with polyethylene inner line) was con-
nected from the syringe to a stainless disposable needle
(27 G, 19 mm) inserted into the muscle. Pain intensity
was rated by the patients using a 0-10 cm electronic
visual analogue scale (VAS) immediately following the
injection and every 5 s until pain was no longer
reported. Time to pain onset, peak pain intensity, time
to peak pain (the point in time when maximum pain
was first reached), mean pain intensity, and area under
the VAS-time graph were extracted.
Participants documented the area of pain on a front
and back view body template. The pain drawings were
subsequently digitized and the pain areas were esti-
mated (Quantify Image, K:L:O:N:K, Sorø, Denmark).
Pain areas that were isolated from the area of local
pain caused by the saline injection were denoted as
referred pain areas. Proximal pain was defined as a
pain area that spread proximal to the knee joint. The
total size of the pain area and the areas of referred
pain were calculated.
Clinical pain drawings
The patients with chronic neck-shoulder pain (NSP)
shaded-in their painful areas on three separate body
templates (front and back views)[50]; one drawing for
their ‘current pain’,o n ef o rt h e i r‘least pain’ during the
last week, and one for their ‘worst pain’ during the last
week. The areas on the pain drawings were measured in
square millimeters and calculated as percentage of the
total body template area using a commercial software
program (Quantify One; K:L:O:N:K, Sorø, Denmark), a
method that has been shown to be reliable for quantify-
ing pain drawings [51,52].
Questionnaire
The questionnaire comprised pain intensity ratings and
instruments concerning various aspects of pain and psy-
chological factors.
Pain intensity regarding clinical pain in the neck and
shoulder regions was rated on a 0-100 mm paper visual
analogue scale (VAS) with the defined end points “no
pain” and “worst possible pain”.A l lt h eq u e s t i o n s
regarding pain concerned the previous 30 days.
Karolinska Sleep Questionnaire (KSQ) was used to
assess sleep disturbances and fatigue over the past six
months [53]. KSQ comprises 15 items rated on a 5-
point scale and three indices: “awakening problems”
(denoted KSQ-Aw), “daytime sleepiness” (denoted KSQ-
Dst), and “sleep disturbances” (denoted KSW-Sd) were
calculated from 12 of the 15 items.
Hospital Anxiety and Depression Scale (HADS) is a
self-rating scale in which the severity of anxiety and
depressive symptoms is rated on a 4-point scale. Seven
questions are related to anxiety and seven to depression,
each with a score range of 0-21. A score of 7 or less
indicates a non-case, a scoreo f8 - 1 0ad o u b t f u lc a s e ,
and 11 or more a definite case [54].
Anxiety Sensitivity Index (ASI) is a 16-item self-
report questionnaire. Each item asks about the amount
of fear the participant experiences in regard to bodily
sensations commonly associated with anxiety. Partici-
pants are asked to rate each item on a 5-point Likert-
like scale ranging from very little (0) to very much (4).
The ratings on the 16 items are summed for a total ran-
ging from 0 to 64 [55].
Pain Anxiety Symptoms Scale-20 (PASS-20) mea-
sures fear and anxiety responses specific to pain [56,57].
The PASS-20 has four 5-item subscales that measure
avoidance, fearful thinking, cognitive anxiety and physio-
logical responses to pain. Participants rate each item on
a 6-point scale ranging from never (0) to always (5).
Pain Catastrophizing Scale (PCS), a 13-item self-
report measure designed to assess catastrophic thoughts
or feelings accompanying the experience of pain.
Respondents are asked to reflect on past painful
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the 13 thoughts or feelings are experienced when in
pain. The questionnaire uses a 5-point scale ranging
f r o m0( n o ta ta l l )t o4( a l lt h et i m e )a n d ,i nt h i ss t u d y ,
we used the total sum score [58,59].
Fear-Avoidance Beliefs Questionnaire (FABQ) was
used to assess fear-avoidance beliefs. The FABQ is a 16-
item self-report questionnaire aimed at quantifying the
beliefs of how work and physical activity affect pain and
whether they should be avoided. The two subscales,
fear-avoidance beliefs for work (FABQwork) and fear-
avoidance beliefs for physical activity (FABQphysical),
are scored on a 7-point Likert scale (0-6) ranging from
‘strongly disagree’ to ‘strongly agree’, where higher sum
scores indicate stronger fear-avoidance beliefs [60].
Pain Disability Index (PDI), a 7-item self-report
i n s t r u m e n tb a s e do na1 0 - p o i n ts c a l et h a ta s s e s s e sp e r -
ception of the specific impact of pain on disability that
may preclude normal or desired performance of a wide
range of functions, such as family and social activities,
sex, work, life-support (sleeping, breathing, eating), and
activities of daily living [61,62].
Statistics and Data analysis
Statistical analyses were performed in SPSS version 17
(SPSS Inc.) and SIMCA -P+ version 12.0 (Umetrics Inc).
Statistical significance was defined as p < .05. Differ-
ences between groups (NSP and CON) in pain sensitiv-
ity measurements and questionnaire scores were
analyzed using Mann-Whitney U-tests. Spearman corre-
lation coefficients (rho) were calculated to analyze possi-
ble relationships between PPT and hypertonic saline-
evoked pain and between pain sensitivity measurements
and questionnaire scores. In the Tables the median and
range values are given for each variable.
Principal component analysis (PCA), using SIMCA-P
+, was used to investigate multivariate correlations
between pain variables and psychological variables
within the NSP-group. PCA can be viewed as a multi-
variate correlation analysis. Related methods such as fac-
tor analysis (i.e., including rotation of the factor
solution) assume a high subject-to-variables ratio is pre-
sent (5-10). But such requirements are not required for
the PCA included in the SIMCA-P+ package. Further-
more a cross validation technique was used to identify
nontrivial principal components (PC). This method
keeps part of the data out from the model development
to assess the predictive power of the model and was
used to test the significance of the components. Hence,
this validation technique increases the stability of the
results. Such validation is not implemented in other
common statistical packages e.g., SPSS. Variables load-
ing upon the same component are correlated and vari-
ables with high loadings but with different signs are
negatively correlated. Variables with absolute loadings
>0.20 and that had a 95% confidence interval not equal
to zero were considered significant. Significant variables
with high loadings (positive or negative) are more
important for the component under consideration than
variables with lower absolute loadings. Variables of a
certain principal component with significant loadings
and the same sign are positively correlated while load-
ings of variables with different signs denote negative
correlations. The obtained principal components are per
definition not correlated and are arranged in decreasing
order with respect to explained variation. R
2 describes
the goodness of fit - the fraction of sum of squares of
all the variables explained by a principal component.
For details concerning PCA see Eriksson et al [63]. Out-
liers were identified using the two powerful methods
available in SIMCA-P+: 1) score plots in combination
with Hotelling’s T2 (identifies strong outliers) and 2)
distance to model in X-space (identifies moderate
outliers).
Results
Neck-shoulder pain
The median intensity and total area sizes of the NSPs’
clinical neck-shoulder pain are presented in Table 1.
According to the pain drawings, current pain afflicted
5.8% (range 1-27%) of the total body surface, pain at its
worst 12.3% (range 3-32) and pain at its least 3.1%
(range 0 -14).
Questionnaire scores
NSP generally perceived aspects of their psychological
situation, including sleeping problems, significantly
worse than CON (Table 1). The only exception was the
ASI, where the two groups had similar scores. Even
though significant differences existed between NSP and
CON the differences were relatively small except for the
PCS.
Pressure pain thresholds
All baseline PPTs over the trapezius and tibialis anterior
muscles were significantly lower in NSP compared with
C O N( T a b l e2 ) .T h ed i f f e r e n c e sb e t w e e ng r o u p sw e r e
smaller for the tibialis anterior than for the trapezius
muscles, bilaterally. The mean values for the three PPT
points of the right trapezius were 228 kPa (SD 87) in
NSP and 450 kPa (SD 117) in CON. The corresponding
values for the left trapezius were 232 kPa (SD 78) and
467 kPa (SD 111).
Induced muscle pain
Hypertonic saline-evoked pain intensity in the tibialis
anterior muscle was significantly higher in NSP, both in
terms of peak pain intensity, mean pain intensity, and
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timing was similar in the two groups as seen in the
measurements of pain onset and time to peak pain
intensity (Table 3).
The pain drawings related to the induced leg muscle
pain revealed a significantly larger spreading of pain,
both regarding total and referred pain area sizes in the
NSP group (Table 3). Proximal spreading of pain was
found in four NSP and two CON subjects. These area
sizes were 139, 169, 1271, 1834 mm
2 and 88, 161 mm
2,
respectively.
Bivariate correlations in NSP
For NSP self-reported duration of chronic neck-shoulder
pain was negatively correlated with baseline PPTs in the
right (rho = -.62, p = .004) and left (rho = -.64, p =
.003) tibialis anterior muscles, but not with PPTs in the
trapezius muscles.
Overall mean PPTs over right and left trapezius were
positively correlated with time to pain onset after hyper-
tonic saline infusion (rho = .53, p = .025 and rho = .49, p
= .041, respectively) in the NSP group. This suggests that
patients with lower thresholds for pressure pain at the site
of clinical pain experience a faster onset of hypertonic sal-
ine-induced pain in the distant area (i.e., tibialis anterior).
The NSP subjects’ mean pain intensity after hyper-
tonic saline infusion was negatively correlated with
PPTs in the right (rho = -.56, p = .016) and left (rho =
-.53, p = .024) tibialis anterior muscles. Furthermore,
the maximum hypertonic saline-induced pain intensity
was negatively correlated with PPTs in right tibialis
anterior (rho = -.58, p = .013) in NSP. Thus, there
seems to be a relationship between pressure pain sensi-
tivity in the lower leg, i.e., an area distant from the site
of clinical pain, and the intensity of hypertonic saline-
induced pain in the same area.
Table 1 Median and range values for clinical neck-shoulder pain intensity ratings, size of pain areas and different
psychological instruments for the trapezius myalgia group (NSP) and for the controls (CON)
NSP (n = 19) Median (range) CON (n = 30) Median (range) p-value
Clinical neck pain intensity (VAS mm) 69 (40-90) 0 (0-20) <.001
Clinical shoulder pain intensity (VAS mm) 67 (19-88) 0 (0-3) <.001
Pain duration (months) 120 (36-273) NA
Current pain area size (mm
2) 788 (150-3616) NA
Worst pain area size (mm
2) 1658 (433-4344) NA
Least pain area size (mm
2) 420 (13-1829) NA
Awakening problems (KSQ-Aw) 2 (.3-3.3) 1 (0-2.7) <.001
Sleep disturbances (KSQ-Dst) 2 (1-3.5) 1 (0-3.5) <.001
Daytime sleepiness (KSQ-Sd) 1.4 (.2-2.6) .6 (0-2.2) <.001
Depression (HADS-D) 3 (1-13) 1 (0-5) <.001
Anxiety (HADS-A) 4 (0-17) 2 (0-10) .003
Anxiety sensitivity (ASI) 10 (1-33) 8 (2-35) .225
Pain anxiety (PASS-20) 37 (17-70) NA
Catastrophizing (PCS) 15 (6-29) 2 (0-21) <.001
Fear-avoidance, physical activity (FABQphysical) 10 (4-17) NA
Fear-avoidance, work (FABQwork) 22 (0-42) NA
Pain disability (PDI) 25 (13-56) NA
P-values for differences between groups were derived from Mann-Whitney U-tests. NA denotes not applicable.
Abbreviations: KSQ = Karolinska sleep questionnaire, KSQ-Aw = KSQ- subscale “awakening problems”, KSQ-Dst = KSQ- subscale “daytime sleepiness”, KSW-Sd =
KSQ- subscale “sleep disturbances”, HADS = hospital anxiety and depression scale; HADS-D = depression subscale of HADS, HADS-A = anxiety subscale of HADS,
ASI = anxiety sensitivity index, PASS = pain anxiety symptoms scale, PCS = pain catastrophizing scale; FABQ = fear-avoidance beliefs questionnaire, FABQphysical
= subscale fear-avoidance beliefs for physical activity of FABQ, FABQwork = subscale fear-avoidance beliefs for work of FABQ, PDI = pain disability index.
Table 2 Median and range values for baseline pressure pain thresholds (PPT, kPa) for the mean of the three sites (T1
+T2+T3) in the trapezius muscles and the single site in the midportion of the tibialis anterior muscles (right and left
sides) for the trapezius myalgia group (NSP) and for the controls (CON)
NSP (n = 19) Median (range) CON (n = 30) Median (range) p-value
PPT Trapezius (mean kPa) Right 213 (113-406) 476 (222-600) <.001
Left 224 (113-405) 492 (188-600) <.001
PPT Tibialis (kPa) Right 567 (140-600) 600 (188-600) .014
Left 487 (239-600) 600 (241-600) .008
P-values for differences between groups were derived from Mann-Whitney U-tests.
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A PCA of NSP yielded a significant model (cumulative
R
2 =. 6 4 )w i t hf o u rp r i n c i p a lcomponents (Table 4).
Component one (PC1) was dominated by the intercorre-
lations between different psychological variables from
the questionnaire. Hence, PASS-20, HADS-D, ASI, PCS,
PDI, FABQwork and all three subscales of the KSQ
were significantly and positively correlated (i.e., had the
same sign).
The second component (PC2) revealed a negative rela-
tionship (i.e., variable loadings with different signs)
between chronic pain duration, clinical neck-shoulder
pain intensities (VAS) and pain intensity after hyper-
tonic saline infusion (VAS peak) on the one hand and
the pain sensitivity measures; PPT tibialis right side and
left side, PPT trapezius right side and time to VAS peak
after hypertonic saline on the other hand. Thus, a long
history of chronic pain and high neck-shoulder pain
intensities were associated with low PPTs not only in
the area of clinical pain but also in distant pain-free
areas. This component also showed a negative
relationship between size of clinical pain areas (current
and worst) and clinical pain intensities.
Component three (PC3) showed a negative relation-
ship between PPT over the right trapezius and clinical
pain areas (current and least) and KSQ-Aw, i.e. indivi-
duals with larger areas of clinical pain had lower PPTs
over the right trapezius muscle.
The fourth component (PC4) revealed positive rela-
tionships between different pain measures and different
psychological variables. The clinical pain area size at its
worst, area under the VAS curve, mean VAS, peak VAS
and the referred pain area after hypertonic saline were
all significantly correlated with HADS-D, HADS-A and
PDI. Symptoms of anxiety and depression were, thus,
associated with increased pain responses to experimental
pain induction and a larger spreading of the neck-
shoulder pain at its worst.
Discussion
Major results of the present study were:
￿ Lower thresholds for pressure pain (PPT) both
within the primary clinical pain region and in
remote pain free areas were found in NSP.
￿ T h eh y p e r t o n i cs a l i n ee v o k e dm u s c l ep a i ni na
remote pain free area was significantly more intense
and more locally widespread in NSP than in CON.
￿ Symptoms of anxiety and depression were asso-
ciated with increased pain responses to experimental
pain induction (i.e., hypertonic saline infusion) and a
larger clinical spreading of the neck-shoulder pain at
its worst in NSP.
￿ A long history of chronic pain and high neck-
shoulder pain intensities were associated with low
PPTs both in the region of clinical pain and in dis-
tant pain-free areas. No correlation existed between
PPTs and the different psychological aspects.
Previous studies of patients with neck-shoulder pain
have reported lower PPTs in painful [9,41,64,65] as well
as distant, non-painful muscles [10,17,66,67] when
Table 3 Median and range values for pain intensity ratings on visual analogue scale (VAS 0-10 cm), and total and
referred pain drawing area sizes (mm
2) after hypertonic saline infusion for the trapezius myalgia group (NSP) and for
the controls (CON)
NSP (n = 19) Median (range) CON (n = 30) Median (range) p-value
Mean VAS (cm) 4.0 (.4-7.9) 2.8 (.8-7.9) .002
Area under VAS curve (cm*s) 1616 (126-2842) 758 (50-2501) .001
Pain onset (s) 25 (0-115) 30 (10-285) .197
Peak VAS (cm) 7.6 (2.0-10.0) 5.0 (1.0-10.0) .006
Time to peak (s) 95 (50-350) 120 (35-655) .335
Total pain area size (mm
2) 234 (36-3193) 113 (4-864) .013
Referred pain area size (mm
2) 65 (0-1376) 0 (0-294) .020
P-values for differences between groups were derived from Mann-Whitney U-tests.
Figure 1 Pain intensity (VAS, cm; mean ± SD) following
hypertonic saline infusion for the trapezius myalgia group
(NSP) and for the controls (CON).
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Page 7 of 12compared to pain-free controls. However, there are also
studies reporting no differences in PPTs in the tibialis
a n t e r i o rm u s c l e si nt h i sp a t ient group [9,41,64,65].
These contrasting results could be due to differences in
patient characteristics. Patients in the current study
reported relatively high clinical pain intensities, with a
median VAS of 69 mm in the neck and 67 mm in the
shoulder region, whereas other studies have reported
lower baseline pain intensities (VAS 25-29 mm [64,65])
or (2.4 - 3.6 on 0 - 10 point scales [9,41]) for these
regions. Moreover, our patients were allowed to have
pain in more than one body region as long as the cri-
teria for widespread pain were not fulfilled; the clinical
pain area size at worst afflicted 12% of the total body
surface. Consequently, the present study possibly inves-
tigated a population with more severe pain than in
some of the previous studies [9,41,64,65]. Thus, as pro-
posed by Chien and Sterling [68] it appears that sensory
hypersensitivity may represent a continuum of augmen-
ted pain processing mechanisms where conditions with
greater symptom levels show more profound changes.
The NSP group displayed signs of widespread muscle
hypersensitivity to two stimuli - i.e., pressure and chemi-
cal stimulation - as evidenced by increased sensitivity to
pressure and hypertonic saline induced pain in the tibia-
lis anterior muscle - a site distant to the primary clinical
pain in the neck- shoulder region. The increased sensi-
tivity to pressure (PPT) was particularly salient in those
patients with a long history of chronic pain, as seen in
the correlation between chronic pain duration and PPTs
in the tibialis anterior muscles (PC2 in Table 4). This
relationship is consistent with the clinical impression of
a tendency towards an anatomical spreading of pain
with time but has to be confirmed in future prospective
studies. Also other studies have shown widespread
hyperalgesia in a wide range of chronic pain conditions,
including WAD [8,9,18,21], fibromyalgia [19,21,69,70],
tension-type headache [16,71], idiopathic neck pain [17],
epicondylalgia [14], pelvic pain syndrome [15], and low-
back pain [13,72]. Based on studies of chronic WAD
[6,9,68,73-76] we recently concluded, that widespread
hypersensitivity of pressure can be present without
widespread clinical pain [77], which is in agreement
with the present results.
Our findings of widespread hypersensitivity of mainly
muscle tissue support the suggestions that central
pathogenic mechanisms are involved in chronic neck-
shoulder pain. Widespread hyperalgesia found in deep
tissues has been proposed to occur as a result of sensiti-
zation of central nervous system nociceptive pathways
or changes in endogenous descending pain modulation
mechanisms [18,78]. The widespread alterations of PPT
in chronic WAD have been discussed with respect to
possible pathophysiological mechanisms: a more or less
continuous nociceptive input [79], peripheral nociceptor
sensitization [9], secondary hyperalgesia in the primary
pain region arising from primary cervical musculoskele-
tal pathology [79], or a generalized state of
Table 4 Outcome of the multivariate correlation analysis
(principal component analysis; PCA) in the trapezius
myalgia group (NSP; n = 19)
PC1 PC2 PC3 PC4
Clinical neck-shoulder pain
Current pain area size 0.20 -0.22 0.21 0.16
Worst pain area size 0.08 -0.27 0.17 0.29
Least pain area size 0.02 0.01 0.32 0.02
Pain duration 0.18 0.21 0.02 0.08
Neck pain intensity -0.13 0.30 -0.17 0.00
Shoulder pain intensity 0.04 0.30 -0.19 -0.12
Pain after hypertonic saline infusion
Area under VAS curve 0.18 0.13 0.05 0.30
Mean VAS 0.19 0.14 0.10 0.37
Pain onset -0.09 -0.10 -0.40 0.09
Peak VAS 0.14 0.22 0.12 0.36
Time to peak 0.00 -0.26 -0.15 0.04
Total pain area size 0.13 -0.18 0.04 0.27
Referred pain area size 0.07 -0.28 0.01 0.20
Pressure pain thresholds
Mean PPT Trapezius
right
0.05 -0.21 -0.30 0.00
Mean PPT Trapezius left 0.08 -0.30 -0.17 0.00
Tibialis right -0.10 -0.31 0.07 -0.15
Tibialis left -0.15 -0.25 -0.03 -0.10
Psychological factors
KSQ-Aw -0.29 0.02 0.28 -0.02
KSQ-Dst -0.27 0.02 0.23 -0.06
KSQ-Si -0.26 0.09 0.14 0.02
HADS-A -0.20 0.09 -0.28 0.30
HADS-D -0.29 0.06 -0.07 0.24
ASI -0.31 0.06 0.16 0.18
PASS-20 -0.28 -0.12 0.10 0.19
PCS -0.32 -0.14 -0.15 0.15
PDI -0.20 0.12 -0.26 0.26
FABQphysical -0.08 -0.10 0.13 0.18
FABQwork -0.27 0.01 0.21 -0.13
Explained
variance
R
2 0.21 0.19 0.14 0.10
Variable loadings upon the principal components (PC) in bold indicate
variables of significant importance for the component. At the bottom line is
given the explained variation (R
2) of each significant component (PC1-4).
Abbreviations: VAS = visual analogue scale, Abbreviations: KSQ = Karolinska
sleep questionnaire, KSQ-Aw = KSQ- subscale “awakening problems”, KSQ- Dst
= KSQ- subscale “daytime sleepiness"(denoted), KSW-Sd = KSQ- subscale
“sleep disturbances”, HADS = hospital anxiety and depression scale; HADS-D =
depression subscale of HADS, HADS-A = anxiety subscale of HADS, ASI =
anxiety sensitivity index, PASS = pain anxiety symptoms scale, PCS = pain
catastrophizing scale; FABQ = fear-avoidance beliefs questionnaire,
FABQphysical = subscale fear-avoidance beliefs for physical activity of FABQ,
FABQwork = subscale fear-avoidance beliefs for work of FABQ, PDI = pain
disability index.
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Page 8 of 12hypersensitivity [79]. Several of the proposed peripheral
and central mechanisms may be present simultaneously
within the primary pain area and consequently be con-
tributing in a complex way to pain and hypersensitivity
in this area, whereas widespread spatial alterations rea-
sonably are linked mainly to central mechanisms. How-
ever, there are several indications that central alterations
in nociceptive processing can be driven by peripheral
tissue alterations [76] and peripheral nociceptive input
[80,81] also in the chronic stage of a pain condition.
Studies using varoius types of blocks indicate a signifi-
cant peripheral nociceptive input contributing to the
alterations in PPT and thermal pain thresholds [80,81].
PPT as well as hypertonic saline induced pain are psy-
chophysical tests and as stated in the introduction can
be influenced by different factors e.g., current clinical
pain intensity and psychological issues. The relationship
to clinical pain intensity and psychological aspects in
chronic WAD are either conflicting [6,9] or not present
[9,68,73-75,77]. Similarly, there seems to be very little
association between psychological variables (i.e., sleeping
problems, depression, anxiety, catastrophizing and fear-
avoidance beliefs) and PPT in different anatomical
regions in the present NSP population. Although it was
evident that NSP showed widespread hypersensitivity
with respect to PPTs (Table 2), PPTs were more directly
connected to the pain intensity per se - the sensory
aspects of chronic pain (cf. PC3 in Table 4) - rather
than the investigated psychological aspects such as
symptoms of anxiety and depression.
In the present study neither the bivariate nor the mul-
tivariate analysis revealed correlations between PPTs
and psychological aspects. We have recently reported
similar results based on multivariate analyses in patients
with chronic WAD without widespread clinical pain
[77]. Furthermore, we and others have concluded that
cold and heat pain thresholds seem to be more strongly
correlated with psychological variables and thereby
linked to the emotional aspects of pain [5,6,77].
I nN S Pi tw a se v i d e n tt h a ts i g n i f i c a n tc o r r e l a t i o n s
existed between pain intensity aspects after induced
pain (i.e., intramuscular saline infusion), clinical pain
drawing area size and certain psychological aspects (PC4
in Table 4). Hence, more intense symptoms of anxiety
and depression together with a higher disability level
were associated with increased pain responses to experi-
mental pain induction and a larger area size of the clini-
cal neck-shoulder pain at its worst. These results
indicate that the investigated psychological status inter-
acted with the perception, intensity, duration and distri-
bution of induced pain in NSP together with the size of
the clinical pain area on the drawing. When interpreting
the results from tests of induced muscle pain a bio-psy-
cho-social model is reasonably important. According to
the present results muscle pain elicited due to chemical
stimuli, but not by pressure, was linked to the psycholo-
gical status of patients with chronic pain, but this has to
be confirmed in other studies. Reasons for these differ-
ences between pressure and chemical stimuli can be due
to the duration of the nociceptive stimuli during the
PPT measurements (parts of seconds) and during the
hypertonic saline infusion (several minutes). Interest-
ingly, a study of chronic WAD reported that psychologi-
cal factors were linked to heat and cold pain thresholds
obtained from the skin, while regarding pressure only a
very brief nociceptive stimuli is involved [77]. Hence,
stimuli duration, and type of stimulus and tissue pro-
voked, may influence the degree of strength between
pain threshold and psychological status.
According to the second component (PC2) in Table 4
significant intercorrelations existed among the four pain
sensitivity aspects covered in this study; i.e., clinical pain
intensities, pain area size, induced pain (peak VAS and
time to peak) and PPT (for 3 out of 4 muscles). Hence,
high neck-shoulder pain intensities and long clinical
pain duration were associated with high peak VAS and
a short time to peak VAS after intramuscular saline and
low PPTs. Surprisingly, according to the second compo-
nent, the above mentioned aspects also correlated with
small area sizes of clinical pain. Instead, larger pain
drawing areas appeared to be associated with increased
levels of anxiety and depression according to PC3 and
awakening problems in PC3 (Table 4).
Methodological considerations
With the present study design it was not possible to
determine if the sensory hypersensitivity occurred as a
direct result of chronic pain or if it was a pre-existing
characteristic that predisposes some individuals to
develop chronic pain. In some subjects, the local pain
area after hypertonic saline infusion expanded to areas
where referred pain usually arises in this region. In
such conditions, the referred pain area will, by defini-
tion, be included in the local pain area, resulting in
underestimates of the number of subjects with referred
pain.
In the present study we have recruited subjects with
chronic neck pain without trauma. We also have related
and contrasted our results to studies concerning chronic
WAD. However, the question arises if chronic WAD is
a separate category compared to other chronic neck
pain conditions? There is no consensus in the literature
as briefly reviewed by Verhagen and co-workers [82];
the label mechanical neck disorders are used with var-
ious definitions by some authors. Independent of choice
it must be pointed out that categories and diagnoses
within this area are not based upon pathophysiological
or pathoanatomical mechanisms.
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component analysis; PCA) to investigate the complex
multivariate correlation pattern between the psycho-
physical tests and different psychological variables.
Such methods have not been applied in earlier studies
investigating the relationships being in focus of this
study. The applied multivariate method can handle low
subject-to-variables ratios. The PCA implemented in
the statistical package used in the present study (i.e.,
SIMCA-P+) includes, in contrast to other statistical
packages (e.g., SPSS), a cross-validation technique in
order to achieve stable and valid principal components.
However, the multivariate correlation analysis should
be viewed mainly as a hypothesis generating method,
given the sample size, rather than as a complete model
of the interactions between the included variables. To
confirm our findings, more experimental research is
needed.
Conclusions
The present study suggests that central sensitization
mechanisms are involved in chronic non-traumatic
neck-shoulder pain without simultaneous clinical wide-
spread pain since sensory hypersensitivity was found in
areas distant to the region of clinical pain. A long his-
tory of chronic pain and high neck-shoulder pain inten-
sities were associated with low PPTs both in the region
of clinical pain and in distant pain-free areas. Both pres-
sure pain thresholds and chemically induced pain inter-
correlated with intensity and area size of the clinical
pain. Only the sensitivity to chemically induced pain
was associated with the psychological status of the NSP
subjects.
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